New cancer nanomedicine reduces pancreatic tumour growth

From an article at Phys.org:

Australian cancer researchers have developed a highly promising nanomedicine that could improve treatment for pancreatic cancer – the most deadly cancer in Australia.

Australian cancer researchers have developed a highly promising technology to deliver gene-silencing drugs to treat pancreatic cancer – the most chemo-resistant and deadly cancer in Australia.
When tested in mice, the new nanomedicine resulted in a 50 per cent reduction in the growth of tumours and reduced the spread of pancreatic cancer.
The UNSW-led research, published in the Biomacromolecules journal, provides new hope for pancreatic cancer patients, most of whom succumb to the disease within three to six months of diagnosis.

 

Read more

timthumb.php_

Recent News

 

2018-03-22T14:36:42+00:00

Leave A Comment